Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.

Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.

http://www.wikidata.org/entity/Q38123911

about

Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells Neuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation.Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2.Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design.Thymoquinone recovers learning function in a rat model of Alzheimer's disease.Mutations in the β-amyloid precursor protein in familial Alzheimer's disease increase Aβ oligomer production in cellular models.

P2860

Q28385402-AF8133AB-9CA0-4AC3-AC18-E49843B37101 Q33702624-D133493D-D468-4CDC-98BD-6E2E25D91785 Q37348968-D0A9AAB1-0A82-4123-A824-8747714F17EF Q38256360-20B5CB18-C403-451B-B2E0-E7336858C39B Q38259551-C7E59884-EE93-4F5B-9E30-7CF7C8577C74 Q38601445-F4C8F733-5ADD-4762-9675-D1FAB82B1C6C Q52654614-99AB5E0B-3F53-4559-8AAD-E82C0BB57A61 Q55082240-9A57EF74-3ABA-48BE-A394-6228E295066F Q55306359-4A44B65C-7523-4CC0-87D3-9BE5215DCF51

P2860

Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.

http://www.wikidata.org/entity/Q38123911

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.

@en

type

label

Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.

@en

prefLabel

Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.

@en

P1433

Q38123911-2CB2F006-3D9E-4E70-B816-D348E9B7D236

P1476

Q38123911-39DE8F1C-560C-432C-9ADA-53985D14F1E3

P2093

Q38123911-BA889CB8-7CFF-47D5-984E-E1BD85350DE0

P2860

Q38123911-0AB602E7-3647-4B0A-8393-877EE6422AE8

Q38123911-0B6A6843-6D1E-42AC-AD4E-693340AFEB6D

Q38123911-0E086AA6-2C54-433A-8132-ACE2AC89240D

Q38123911-0EA8B2D8-4FFE-461D-B4C3-B8860A3CA4BF

Q38123911-0EAED689-67D5-4C8B-BCFA-F0E0A2870193

Q38123911-0FFB7AB3-F9BB-4807-9AB6-4633871AEEC7

Q38123911-106AC3AB-FD2E-4D06-8E96-180ED4DFAC5C

Q38123911-11931988-65DF-4FDE-BB2D-A7367C3027E6

Q38123911-11B9725B-95AD-4097-93C5-F79F253D0A8E

Q38123911-15079623-BB7A-49E3-A8C8-B6D5AC1100D2

P304

Q38123911-A8CC3AFC-84F6-4AC5-BEB1-6180C62CABC4

P31

Q38123911-5E6AA6BB-5B2F-44D5-8552-23CD786FD9C9

Q38123911-CED15A38-1EC2-4CE9-ACEF-09BA6F31B1D6

P356

Q38123911-AEBEAA84-1BC9-44AE-B993-757E1E6550D5

P433

Q38123911-79E64FD5-D791-48B1-A433-98184B1A2EE3

P478

Q38123911-9A01B2A3-B6A2-49A5-9E68-70AB235E2EB3

P577

Q38123911-D5279CFF-73EF-4A04-AA5C-BC25F6239166

P698

Q38123911-A0FC938A-56F5-4563-BF91-D788BCB51D3F

P921

Q38123911-401226A5-2401-4C8D-8B9D-B099B227385C

Q38123911-8CA530F7-CA4D-4C2B-95B1-979CECA74BA6

Q38123911-BEB03F49-17E2-4EAE-A058-E788F0CDEADC

Q38123911-CDB4887C-C3D6-4BDE-A235-F83327ECC341

P932

Q38123911-F8EE0EF7-8133-40FA-AB28-0490295B935B

P356

P1433

Proceedings of the Japan Academy, Series B

P1476

Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.

@en

P2093

Takaomi C Saido

http://www.w3.org/2001/XMLSchema#string

P2860

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

Neuropathological stageing of Alzheimer-related changes

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

Inflammation and Alzheimer's disease

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

Oxidized neprilysin in aging and Alzheimer's disease brains

P304

321-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2183/PJAB.89.321

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23883611

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

membrane proteins

P932

3758963

http://www.w3.org/2001/XMLSchema#string